Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate

Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are major causes of blindness globally. The primary treatment option for DME and neovascular AMD (nAMD) is anti-vascular endothelial growth factor (VEGF) compounds, but this treatment modality often yields insufficient results, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vofo, Brice Nguedia, Chowers, Itay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295757/
https://www.ncbi.nlm.nih.gov/pubmed/37371657
http://dx.doi.org/10.3390/biomedicines11061562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295757/
https://www.ncbi.nlm.nih.gov/pubmed/37371657
http://dx.doi.org/10.3390/biomedicines11061562

Ejemplares similares